Skip to main content
BF-BBrown Forman IncSell4.8·$27.81+0.04%
BF-B · Why this verdict

Why Brown Forman (BF-B) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.8/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

A well-run consumer defensive business with 18% operating margins and a near-perfect Piotroski financial-health score, but the stock has moved above its near-term technical target — presenting negative net upside — while 3 of the past 4 quarterly earnings reports were misses including the most recent; the setup favors patience rather than fresh exposure.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Short interest stands at 13% of float, indicating that a material share of the market is positioned against the stock; this elevated short base creates ongoing overhead selling pressure and suggests institutional skepticism about the near-term earnings trajectory.

Stable
Key risks
Expectation
Short interest falls below 7% of float for 2 consecutive months as bearish conviction fades.

CounterHigh short interest can become a source of upside fuel if the company posts a surprise beat, as short-covering can amplify any positive price move beyond what fundamentals alone would drive.

Strong operating margins of 18%, a Piotroski F-Score of 8 out of 9, and solid cash flow conversion establish genuine franchise quality, but a PEG of 4.33 and a forward P/E of 15.8 times price in growth the company has not yet delivered, leaving the valuation dependent on an earnings acceleration that has not arrived.

Stable
Quality breakdown
Expectation
Annual EPS grows more than 20% year-over-year for 2 consecutive fiscal years, compressing the PEG to below 2.0 and justifying the current multiple.

CounterHigh-quality consumer defensive businesses have historically held premium multiples through prolonged growth droughts; if the category cycle turns, earnings can recover faster than consensus currently anticipates.

The current price has moved above the near-term resistance target, leaving a negative net upside of approximately 0.5%; at this level the risk/reward is unfavorable and there is no price cushion to absorb any negative news without an immediate loss.

Stable
Price targets
Expectation
Analyst consensus target is raised more than 15% above the current price of $26.94, re-opening a meaningful upside gap.

CounterA recovery setup with improving MACD and rising on-balance volume suggests momentum could carry price modestly higher from here even beyond the current technical target, particularly if broader market sentiment stays constructive.

Three of the past four quarterly earnings reports were misses, including the most recent quarter which came in 62.65% below consensus — a pattern that signals management guidance is unreliable or operating pressures are not being adequately reflected in forward estimates.

Stable
Earnings
Expectation
EPS surprise exceeds 5% for 2 consecutive quarterly reports, signaling the miss pattern has reversed.

CounterOne of the four quarters was a strong beat at 24.68% above estimate, and the two earlier misses were very small (-1.46% and -1.86%), suggesting the most recent deep miss may be a one-time event rather than a structural delivery problem.

Per-dimension breakdown

Value

5.3/10data confidence 100%
ComponentSub-score
P/E7.0
P/S8.1
EV/EBITDA4.3
Fwd P/E7.6
PEG2.8
Analyst target3.0
  • Forward P/E: 16.3x
  • PEG: 4.46

Quality

7.8/10data confidence 100%
ComponentSub-score
ROE5.9
ROA5.8
Gross margin8.1
Op margin9.3
Net margin9.1
Current ratio9.8
FCF quality7.2
Moat6.5
Piotroski F8.9
  • Strong margins: 18%
  • Strong Piotroski F-Score: 8/9
  • High-quality business

Growth

1.5/10data confidence 67%
ComponentSub-score
Rev growth3.0
EPS growth0.0

Momentum

6.5/10data confidence 100%
ComponentSub-score
RSI4.4
MACD10.0
OBV10.0
MA position8.0
Volume0.0
  • Overbought (RSI 73)
  • Volume accumulation (rising OBV)
  • Above 200-MA but MA slope flat

Sentiment

4.8/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target5.0
erm sentiment4.1

Insider

5.0/10data confidence 50%

Peer rank

3.8/10data confidence 80%
ComponentSub-score
value rank5.0
quality rank1.7
growth rank3.3

Technical

3.6/10data confidence 100%
ComponentSub-score
bollinger1.1
support resistance0.6
52w position6.7
gap6.0

Risk (lower is worse)

5.9/10data confidence 100%
ComponentSub-score
short interest3.7
days to cover6.1
volatility5.4
put call5.9
max pain risk3.0
beta10.0
debt equity7.1
  • Above max pain $15
  • Concentration risks: 3 MED (10-K Item 1A)

Catalyst

3.0/10data confidence 100%
ComponentSub-score
erm3.5
earnings history0.0
earnings timing5.0
surprise avg0.0
dividend safety6.5
  • Earnings concerns: 1B/3M
  • Dividend: 331.0%

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:6.5>=5.5
  • INSIDER:OK
  • DEATH_CROSS:QUALITY_MOMENTUM_EXEMPT
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:63d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.8=NEGATIVE
Warning (2)
  • DEATH_CROSS:quality=7.8>=7.5+momentum=6.5>=5.0 exempted
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.84
Upside
-10.0%
Downside
12.0%
Sizing output
AVOID

SetupRECOVERY Death cross but MACD improving, RSI 73

EdgeNO_EDGE No clear edge identified

SuitabilityMODERATE Balanced profile

Investment implication

The F-path SELL output reflects an overall score of 4.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 7.8) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.8=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.84 — supplementary context, not the trigger for this path.

The strongest dimensions are Quality at 7.8, Momentum at 6.5, and Risk (lower is worse) at 5.9; the weakest are Growth at 1.5, Catalyst at 3.0, and Technical at 3.6. The V9 engine flagged 1 failed gate with 2 warnings, producing an asymmetric reward-to-risk of -0.84 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Strong operating margins of 18%, a Piotroski F-Score of 8 out of 9, and solid cash flow conversion establish genuine franchise quality, but a PEG of 4.33 and a forward P/E of 15.8 times price in growth the company has not yet delivered, leaving the valuation dependent on an earnings acceleration that has not arrived.

    Trip ifAnnual EPS grows more than 20% year-over-year for 2 consecutive fiscal years.

  • P2The current price has moved above the near-term resistance target, leaving a negative net upside of approximately 0.5%; at this level the risk/reward is unfavorable and there is no price cushion to absorb any negative news without an immediate loss.

    Trip ifAnalyst consensus target is raised more than 15% above current price of $26.94.

  • P3Three of the past four quarterly earnings reports were misses, including the most recent quarter which came in 62.65% below consensus — a pattern that signals management guidance is unreliable or operating pressures are not being adequately reflected in forward estimates.

    Trip ifEPS surprise exceeds 5% for 2 consecutive quarterly reports.

  • P4Short interest stands at 13% of float, indicating that a material share of the market is positioned against the stock; this elevated short base creates ongoing overhead selling pressure and suggests institutional skepticism about the near-term earnings trajectory.

    Trip ifShort interest falls below 7% of float for 2 consecutive months.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks BF-B Why this verdict